Inflammaging, a targetable pathway for preventing cardiovascular diseases.
Abstract
Inflammaging, characterized by persistent chronic inflammation in older adults, has emerged as a critical factor linked to age-related diseases such as cardiovascular diseases (CVDs), metabolic disorders, and cognitive decline, which collectively contribute to the leading causes of death globally. Elevated levels of cytokines, chemokines, and others inflammatory mediators characterize inflammaging and serve as indicators of biological age. Among the causes of inflammaging, deterioration of the immune system, mitochondrial dysfunction, dysbiosis, accumulation of DAMPs, together with genetic or epigenetic factors, contribute to inflammaging not only in CVD but also in other age-related conditions. This review examines the causes and consequences of inflammaging, particularly its implications for atherosclerosis and heart failure with preserved ejection fraction (HFpEF) and explores potential strategies to mitigate it in the onset of CVD.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper addresses the concept of inflammaging, which is a significant factor in age-related diseases, particularly cardiovascular diseases. By exploring the underlying mechanisms and potential strategies to mitigate inflammaging, it contributes to understanding the root causes of aging and their implications for longevity. However, while it presents solid research, the findings appear to be more of an incremental advance rather than a groundbreaking discovery, limiting its overall impact.
Author of this paper? Send a correction.